HLA-A Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-A monoclonal antibodies for immunology and cell biology research. HLA-A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-A is a critical component of the major histocompatibility complex (MHC) class I molecules, playing a vital role in the immune response by presenting peptide antigens to CD8+ T cells. This function is essential for the recognition and elimination of infected or malignant cells, making HLA-A a key player in both adaptive immunity and cancer immunotherapy. Understanding the expression and regulation of HLA-A is crucial for advancing therapeutic strategies and improving patient outcomes in various diseases. HLA-A research has significant implications for transplantation medicine, autoimmune disorders, and infectious disease studies. Investigating HLA-A expression patterns helps reveal mechanisms of immune evasion in cancer cells and potential therapeutic targets. The development of targeted immunotherapies relies heavily on understanding HLA-A functionality and regulation. Santa Cruz Biotechnology monoclonal antibodies for HLA-A enable researchers worldwide to advance our understanding of immune system function and disease mechanisms.